Bajaj Healthcare Limited (BHL) said that it has launched API and formulation of 2-Deoxy-D-Glucose (2-DG), an antiviral drug used for the treatment of moderate to severe Covid-19, under the brand name — DGJAJ. The APIs, intermediates, and formulations manufacturer had signed a license agreement from the Indian Defence Research and Development Organisation (DRDO) in July […]
Dr. Reddy’s Laboratories has announced the commercial launch of the Defence Research and Development Organisation’s (DRDO) anti-Covid-19 drug 2-deoxy-D-glucose (2-DG). The Indian pharma giant said that it will supply the 2-DG drug to major government and private hospitals in India. In the initial weeks, Dr. Reddy’s Laboratories will make 2-DG available in hospitals in metros […]